Humana Inc. (HUM)

Market Cap	45.17B
Revenue (ttm)	109.24B
Net Income (ttm)	1.99B
Shares Out	120.50M
EPS (ttm)	16.22
PE Ratio	23.11
Forward PE	21.97
Dividend	$3.54 (0.94%)
Ex-Dividend Date	Jun 28, 2024

Volume	1,092,680
Open	373.78
Previous Close	373.49
Day's Range	373.17 - 378.31
52-Week Range	298.61 - 530.54
Beta	0.53
Analysts	Buy
Price Target	403.80 (+7.73%)
Earnings Date	Jul 31, 2024

About HUM

Humana Inc., together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. In addition, the company provid...

• Industry: Healthcare Plans
• Sector: Healthcare
• IPO Date: Jan 22, 1993
• Employees: 67,600
• Stock Exchange: NYSE
• Ticker Symbol: HUM

Financial Performance

In 2023, Humana's revenue was $106.37 billion, an increase of 14.54% compared to the previous year's $92.87 billion. Earnings were $2.49 billion, a decrease of -11.30%.

Analyst Forecast

According to 22 analysts, the average rating for HUM stock is "Buy." The 12-month stock price forecast is $403.8, which is an increase of 7.73% from the latest price.

Price Target

$403.8

(7.73% upside)

Analyst Consensus: Buy